Clare Market Investments’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Clare Market Investments's PFE Position: Q3 2025 in Review
Clare Market Investments reduced its Pfizer (PFE) stake by 31% in Q3 2025, selling an estimated $149K and leaving 13,687 shares worth $349K. The position accounts for 0.07% of the portfolio, ranked #123.
Clare Market Investments first reported a position in PFE in Q4 2018 and has held it in 23 quarters since. The position peaked at $1.69M in Q3 2024. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.
- Clare Market Investments held 13,687 shares of Pfizer worth $349K as of Q3 2025.
- Clare Market Investments sold 6,054 Pfizer shares in Q3 2025, an estimated $149K.
- Pfizer made up 0.07% of Clare Market Investments's portfolio in Q3 2025, its #123 holding.
- Clare Market Investments first reported a position in Pfizer in Q4 2018 and has held it in 23 quarters since.
- Clare Market Investments's Pfizer position peaked at $1.69M in Q3 2024.
- 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.
Based on Clare Market Investments's 13F filing for Q3 2025, filed 12 Nov 2025.